|
Exhibit 2.1
EXECUTION VERSION
AGREEMENT AND PLAN OF MERGER
Dated as of May 11, 2007
among
CARDINAL HEALTH, INC.,
EAGLE MERGER CORP.
and
VIASYS HEALTHCARE INC.
TABLE OF
CONTENTS
| |
|
Page
|
|
ARTICLE I
|
|
|
|
|
|
|
|
THE OFFER
|
|
|
|
|
|
|
|
SECTION 1.01. The Offer
|
|
2
|
|
SECTION 1.02. Company Action
|
|
3
|
|
SECTION 1.03. Board of Directors
|
|
5
|
|
|
|
|
|
ARTICLE II
|
|
|
|
|
|
|
|
THE MERGER; EFFECT OF THE MERGER
ON THE CAPITAL STOCK OF THE CONSTITUENT CORPORATIONS; EXCHANGE OF
CERTIFICATES
|
|
|
|
|
|
|
|
SECTION 2.01. The Merger
|
|
6
|
|
SECTION 2.02. Closing
|
|
6
|
|
SECTION 2.03. Effective Time
|
|
6
|
|
SECTION 2.04. Effects of the Merger
|
|
7
|
|
SECTION 2.05. Certificate of Incorporation and
By-laws
|
|
7
|
|
SECTION 2.06. Directors of the Surviving
Corporation
|
|
7
|
|
SECTION 2.07. Officers of the Surviving
Corporation
|
|
7
|
|
SECTION 2.08. Additional Actions
|
|
7
|
|
SECTION 2.09. Effect on Capital Stock
|
|
8
|
|
SECTION 2.10. Exchange of Certificates
|
|
9
|
|
|
|
|
|
ARTICLE III
|
|
|
|
|
|
|
|
REPRESENTATIONS AND
WARRANTIES
|
|
|
|
|
|
|
|
SECTION 3.01. Representations and Warranties of
the Company
|
|
11
|
|
SECTION 3.02. Representations and Warranties of
Parent and Merger Sub
|
|
32
|
|
|
|
|
|
ARTICLE IV
|
|
|
|
|
|
|
|
COVENANTS RELATING TO THE
BUSINESS
|
|
|
|
|
|
|
|
SECTION 4.01. Conduct of Business
|
|
35
|
|
SECTION 4.02. No Solicitation
|
|
40
|
|
|
|
|
|
ARTICLE V
|
|
|
|
|
|
|
|
ADDITIONAL AGREEMENTS
|
|
|
|
|
|
|
|
SECTION 5.01. Company Stockholders’
Meeting; Merger Without Meeting of Company Stockholders
|
|
43
|
|
SECTION 5.02. Access to Information;
Confidentiality
|
|
44
|
|
SECTION 5.03. Further Action; Efforts.
|
|
45
|
i
|
|
|
46
|
|
SECTION 5.05. Indemnification, Exculpation and
Insurance
|
|
48
|
|
SECTION 5.06. Fees and Expenses
|
|
49
|
|
SECTION 5.07. Public Announcements
|
|
50
|
|
SECTION 5.08. Stockholder Litigation
|
|
50
|
|
SECTION 5.09. Employee Matters
|
|
50
|
|
SECTION 5.10. Takeover Laws
|
|
52
|
|
SECTION 5.11. Company Rights Agreement
|
|
52
|
|
|
|
|
|
ARTICLE VI
|
|
|
|
|
|
|
|
CONDITIONS PRECEDENT TO THE
MERGER
|
|
|
|
|
|
|
|
SECTION 6.01. Conditions to Each Party’s
Obligation to Effect the Merger
|
|
52
|
|
|
|
|
|
ARTICLE VII
|
|
|
|
|
|
|
|
TERMINATION, AMENDMENT AND
WAIVER
|
|
|
|
|
|
|
|
SECTION 7.01. Termination
|
|
53
|
|
SECTION 7.02. Effect of Termination
|
|
54
|
|
SECTION 7.03. Amendment
|
|
55
|
|
SECTION 7.04. Extension; Waiver
|
|
55
|
|
SECTION 7.05. Procedure for Termination or
Amendment
|
|
55
|
|
|
|
|
|
ARTICLE VIII
|
|
|
|
|
|
|
|
GENERAL PROVISIONS
|
|
|
|
|
|
|
|
SECTION 8.01. Nonsurvival of Representations and
Warranties
|
|
55
|
|
SECTION 8.02. Notices
|
|
55
|
|
SECTION 8.03. Definitions
|
|
56
|
|
SECTION 8.04. Interpretation
|
|
59
|
|
SECTION 8.05. Consents and Approvals
|
|
60
|
|
SECTION 8.06. Counterparts
|
|
60
|
|
SECTION 8.07. Entire Agreement; No Third-Party
Beneficiaries
|
|
60
|
|
SECTION 8.08. GOVERNING LAW
|
|
60
|
|
SECTION 8.09. Assignment
|
|
60
|
|
SECTION 8.10. Specific Enforcement; Consent to
Jurisdiction
|
|
61
|
|
SECTION 8.11. WAIVER OF JURY TRIAL
|
|
61
|
|
SECTION 8.12. Severability
|
|
62
|
|
|
|
|
|
Annex A
|
Conditions to the Offer
|
|
|
|
Exhibit A
|
Amended and Restated Certificate of Incorporation
of the Surviving Corporation
|
|
|
ii
INDEX OF DEFINED
TERMS
| |
|
Page
|
|
|
|
|
|
401(k) Termination Date
|
|
51
|
|
Acquisition Agreement
|
|
42
|
|
Actions
|
|
18
|
|
Affiliate
|
|
56
|
|
Agreement
|
|
1
|
|
Antitrust Law
|
|
56
|
|
Appointment Time
|
|
5
|
|
Arrangements
|
|
26
|
|
Business Day
|
|
56
|
|
Certificate
|
|
8
|
|
Certificate of Merger
|
|
6
|
|
Closing
|
|
6
|
|
Closing Date
|
|
6
|
|
Code
|
|
10
|
|
Commonly Controlled Entity
|
|
23
|
|
Company
|
|
1
|
|
Company 401(k) Plan
|
|
51
|
|
Company Adverse Recommendation Change
|
|
41
|
|
Company Balance Sheet
|
|
25
|
|
Company Benefit Agreements
|
|
18
|
|
Company Benefit Plans
|
|
23
|
|
Company Bylaws
|
|
11
|
|
Company Certificate
|
|
7
|
|
Company Common Stock
|
|
1
|
|
Company Director Stock Units
|
|
12
|
|
Company Disclosure Schedule
|
|
11
|
|
Company ESPP
|
|
12
|
|
Company Pension Plan
|
|
23
|
|
Company Personnel
|
|
18
|
|
Company Preferred Stock
|
|
12
|
|
Company Recommendation
|
|
3
|
|
Company Restricted Stock Units
|
|
12
|
|
Company Rights
|
|
32
|
|
Company Rights Agreement
|
|
32
|
|
Company SEC Documents
|
|
15
|
|
Company Stock Options
|
|
12
|
|
Company Stock Plan
|
|
12
|
|
Company Stock-Based Awards
|
|
12
|
|
Company Stockholder Approval
|
|
29
|
|
Company Stockholders
|
|
1
|
|
Company Stockholders’ Meeting
|
|
43
|
|
Company Welfare Plan
|
|
24
|
|
Confidentiality Agreement
|
|
45
|
iii
|
Continuing Employees
|
|
50
|
|
Contract
|
|
14
|
|
Conversion Ratio
|
|
47
|
|
Covered Securityholders
|
|
27
|
|
DGCL
|
|
1
|
|
Dissenting Shares
|
|
8
|
|
DOJ
|
|
45
|
|
EC Merger Regulation
|
|
57
|
|
Effective Time
|
|
7
|
|
End Date
|
|
53
|
|
Environmental Laws
|
|
57
|
|
ERISA
|
|
23
|
|
Exchange Act
|
|
2
|
|
Exchange Agent
|
|
9
|
|
Exchange Fund
|
|
9
|
|
Expenses
|
|
49
|
|
Expiration Date
|
|
2
|
|
FDCA
|
|
20
|
|
Foreign Antitrust Laws
|
|
57
|
|
Foreign Corrupt Practices Act
|
|
21
|
|
FTC
|
|
45
|
|
GAAP
|
|
16
|
|
Government Bid
|
|
57
|
|
Government Contract
|
|
57
|
|
Governmental Entity
|
|
15
|
|
Hazardous Materials
|
|
57
|
|
HSR Act
|
|
15
|
|
Independent Directors
|
|
6
|
|
Infringe
|
|
29
|
|
Intellectual Property
|
|
57
|
|
IRS
|
|
24
|
|
Key Personnel
|
|
57
|
|
Knowledge
|
|
57
|
|
Law
|
|
14
|
|
Liens
|
|
11
|
|
Material Adverse Change
|
|
58
|
|
Material Adverse Effect
|
|
58
|
|
Material Contracts
|
|
19
|
|
Materially Burdensome Condition
|
|
46
|
|
MDD
|
|
20
|
|
Merger
|
|
1
|
|
Merger Consideration
|
|
8
|
|
Merger Option
|
|
4
|
|
Merger Option Shares
|
|
4
|
|
Merger Sub
|
|
1
|
|
Merger Sub Certificate
|
|
32
|
iv
|
Non-U.S. Company Benefit Plan
|
|
23
|
|
Notice of Superior Proposal
|
|
42
|
|
NYSE
|
|
6
|
|
Offer
|
|
1
|
|
Offer Documents
|
|
2
|
|
Offer Price
|
|
1
|
|
Order
|
|
14
|
|
Parent
|
|
1
|
|
Parent Common Shares
|
|
47
|
|
Parent Disclosure Schedule
|
|
32
|
|
Parent Material Adverse Change
|
|
58
|
|
Parent Material Adverse Effect
|
|
58
|
|
Parent Option
|
|
47
|
|
Permits
|
|
20
|
|
person
|
|
59
|
|
Proxy Statement
|
|
43
|
|
Release
|
|
59
|
|
Representatives
|
|
40
|
|
Restraints
|
|
53
|
|
Schedule 14D-9
|
|
3
|
|
SEC
|
|
2
|
|
SEC Staff
|
|
3
|
|
Securities Act
|
|
15
|
|
Significant Subsidiary
|
|
11
|
|
SOX
|
|
15
|
|
Subsidiary
|
|
59
|
|
Superior Proposal
|
|
41
|
|
Surviving Corporation
|
|
6
|
|
Takeover Proposal
|
|
41
|
|
Tax
|
|
59
|
|
Tax Return
|
|
59
|
|
Taxing Authority
|
|
59
|
|
Tender Offer Conditions
|
|
2
|
|
Termination Fee
|
|
49
|
v
This AGREEMENT AND PLAN OF MERGER (this "
Agreement "), dated as of May 11, 2007, among Cardinal
Health, Inc., an Ohio corporation (" Parent "), Eagle Merger
Corp., a Delaware corporation and a wholly owned Subsidiary of
Parent (" Merger Sub "), and VIASYS Healthcare Inc., a
Delaware corporation (the " Company ").
WHEREAS, it is proposed that, on the terms and subject to the
conditions set forth in this Agreement, Merger Sub shall commence a
cash tender offer (such tender offer, as it may be amended and
supplemented from time to time as permitted by this Agreement, the
" Offer ") to purchase all of the issued and outstanding
shares of common stock, par value $0.01 per share, of the Company
(the " Company Common Stock ") at a price per share equal to
$42.75, plus, if the Appointment Time shall not have occurred on or
prior to the 45 th day
after the date of this Agreement, an additional $0.007027 for each
day during the period commencing on the 45 th day after the date of this
Agreement and ending on the date of the Appointment Time, net to
the sellers in cash without interest (such amount or any greater
amount per share paid pursuant to the Offer, the " Offer
Price ");
WHEREAS, it is proposed that, on the terms and subject to the
conditions set forth in this Agreement, following the consummation
of the Offer, Merger Sub shall merge with and into the Company (the
" Merger "), pursuant to which each outstanding share of
Company Common Stock shall be converted into the right to receive
the Offer Price, without interest, except for (i) shares of
Company Common Stock held by holders who comply with the relevant
provisions of the General Corporation Law of the State of Delaware
(the " DGCL ") regarding the right of stockholders to
dissent from the Merger and require appraisal of their shares and
(ii) shares of Company Common Stock held in the treasury of
the Company or owned by Parent, Merger Sub or any other wholly
owned Subsidiary of Parent;
WHEREAS, the Board of Directors of the Company has
(i) approved this Agreement, (ii) determined that the
Offer, the Merger and the other transactions contemplated by this
Agreement are fair to, advisable and in the best interests of the
Company and its stockholders, and (iii) is recommending that
the holders of shares of Company Common Stock (the " Company
Stockholders ") accept the Offer, tender their shares of
Company Common Stock into the Offer, approve the Merger and adopt
this Agreement, in each case, upon the terms and subject to the
conditions set forth in this Agreement; and
WHEREAS, each of the Board of Directors of Parent and Merger Sub
has (i) approved this Agreement and (ii) has determined
that the Offer, the Merger and the other transactions contemplated
by this Agreement are fair to, advisable and in the best interests
of their respective corporations.
NOW, THEREFORE, in consideration of the representations,
warranties, covenants and agreements contained in this Agreement,
and subject to the conditions set forth herein, the parties hereto
agree as follows:
ARTICLE I
THE OFFER
SECTION 1.01. The Offer .
(a)
Provided that this Agreement shall not have been
terminated in accordance with Article VII and none of the events or
conditions set forth in Annex A (other than clause (e) of Annex A)
shall have occurred and be existing and shall not have been waived
by Parent or Merger Sub (the conditions set forth in Annex A, the "
Tender Offer Conditions "), Merger Sub shall commence
(within the meaning of Rule 14d-2 under the U.S. Securities
Exchange Act of 1934, as amended (together with the rules and
regulations thereunder, the " Exchange Act ")), as promptly
as reasonably practicable after the date of this Agreement and in
any event within 8 Business Days after the date of this Agreement,
the Offer. Without the prior written consent of the Company,
Merger Sub shall not decrease the Offer Price or change the form of
consideration payable in the Offer, decrease the number of shares
of Company Common Stock sought to be purchased in the Offer, impose
conditions to the Offer in addition to the Tender Offer Conditions,
change or waive the Minimum Condition or, except as provided in
Section 1.01(c), extend the expiration of the Offer beyond the
initial Expiration Date, or amend any other term of the Offer in a
manner adverse to the Company Stockholders; provided that
Merger Sub expressly reserves the right to increase the Offer Price
and to waive any condition of the Offer, except the Minimum
Condition. The Company agrees that no shares of Company
Common Stock held by the Company or any of its Subsidiaries will be
tendered in the Offer.
(b)
Merger Sub shall file with the U.S. Securities and
Exchange Commission (the " SEC ") a Tender Offer Statement
on Schedule TO with respect to the Offer on the date that the Offer
is commenced, which Tender Offer Statement shall include an offer
to purchase, form of transmittal letter and form of notice of
guaranteed delivery (together with any supplements or amendments
thereto, collectively, the " Offer Documents ") and, subject
to the Company’s compliance with Section 1.02(c), cause the
Offer Documents to be disseminated to the Company Stockholders in
accordance with the applicable requirements of the U.S. federal
securities laws. The Company, Parent and Merger Sub each
agree promptly to correct any information provided by it for use in
the Offer Documents if and to the extent that it shall have become
false or misleading in any material respect, and Parent further
agrees to take all steps necessary to cause the Offer Documents as
so corrected to be filed with the SEC and disseminated to the
Company Stockholders to the extent required by applicable
Law. The Company shall promptly furnish to Parent and Merger
Sub all information concerning Company that is required or
reasonably requested by Parent or Merger Sub in connection with the
obligations relating to the Offer Documents contained in this
Section 1.01(b). The Company and its counsel shall be given
the opportunity to review and comment on the Offer Documents
sufficiently in advance of filing with the SEC or dissemination to
the Company Stockholders.
(c)
Subject to the terms and conditions thereof, the
Offer shall remain open until midnight, New York City time, at the
end of the 20th Business Day after the date that the Offer is
commenced (the " Expiration Date "), unless Merger Sub shall
have extended the period of time for which the Offer is open
pursuant to, and in accordance with, the two succeeding sentences
or as may be required by applicable Law, in which event the term "
Expiration Date "
2
shall mean the latest time and date as the Offer,
as so extended may expire; provided, however , that Merger
Sub may, without the consent of Company, (i) extend the Offer for
one or more periods of not more than five Business Days if, at the
scheduled Expiration Date, any of the conditions of the Offer shall
not have been satisfied or waived; (ii) extend the Offer for any
period required by any rule, regulation, interpretation or position
of the SEC or the staff of the SEC (the " SEC Staff ")
thereof applicable to the Offer; or (iii) if all of the Tender
Offer Conditions are satisfied but the number of shares of Company
Common Stock that have been validly tendered and not withdrawn in
the Offer, together with any shares of Company Common Stock then
owned by Parent, is less than 90% of the outstanding shares of
Company Common Stock, commence a subsequent offering period
(as provided in Rule 14d-11 under the Exchange Act) for three to 20
Business Days to acquire outstanding shares of Company Common
Stock.
(d)
Subject to the terms and conditions set forth in
this Agreement and to satisfaction or waiver of the Tender Offer
Conditions, Merger Sub shall, and Parent shall cause it to, as soon
as practicable after the Expiration Date, accept for payment and
pay for (after giving effect to any required withholding Tax) all
shares of Company Common Stock that have been validly tendered and
not withdrawn pursuant to the Offer. If Merger Sub shall
commence a subsequent offering period in connection with the Offer,
Merger Sub shall accept for payment and pay for (after giving
effect to any required withholding Tax) all additional shares of
Company Common Stock validly tendered during such subsequent
offering period.
SECTION 1.02. Company Action .
(a)
The Company hereby approves of and consents to the
Offer, and represents and warrants that the Board of Directors of
the Company, at a meeting duly called and held, has, subject to the
terms and conditions set forth in this Agreement, unanimously
(i) approved this Agreement, and deemed this Agreement, the
Offer, the Merger and the transactions contemplated by this
Agreement advisable, fair to and in the best interests of the
Company Stockholders; (ii) approved and adopted this Agreement and
the transactions contemplated by this Agreement, including the
Offer and the Merger, in all respects, and such approval
constitutes approval of the Offer, the Merger, this Agreement and
the transactions contemplated by this Agreement for purposes of
Section 203 of the DGCL; and (iii) resolved to recommend that the
Company Stockholders accept the Offer, that the Company
Stockholders tender their shares of Company Common Stock in the
Offer to Merger Sub, and that the Company Stockholders approve and
adopt this Agreement and the Merger to the extent required by
applicable Law (the " Company Recommendation "). The
Company consents to the inclusion of the Company Recommendation in
the Offer Documents, subject to Section 4.02(b).
(b)
The Company hereby agrees to file with the SEC, as
soon as reasonably practicable on the day that the Offer is
commenced, a Solicitation/Recommendation Statement on Schedule
14D-9 pertaining to the Offer (together with any amendments or
supplements thereto, the " Schedule 14D-9 ") that, subject
to Section 4.02(b), contains the Company Recommendation and to
promptly mail the Schedule 14D-9 to the Company Stockholders
together with the Offer Documents and cause the Offer Documents and
the Schedule 14D-9 to be disseminated to the Company Stockholders,
in each case as and to the extent required by, and in accordance
with the applicable requirements of the U.S. federal securities
laws. Parent, Merger Sub and their counsel shall be given the
opportunity to review and comment on the Schedule
3
14D-9 sufficiently in advance of its filing with
the SEC. The Company will use its reasonable best efforts to
cause the Schedule 14D-9 to comply in all material respects with
the applicable requirements of the U.S. federal securities
laws. The Company, Parent and Merger Sub each agree promptly
to correct any information provided by it for use in the Schedule
14D-9 if and to the extent that it shall have become false or
misleading in any material respect, and the Company further agrees
to take all steps necessary to cause the Schedule 14D-9 as so
corrected to be filed with the SEC and disseminated to the Company
Stockholders to the extent required by applicable Law. Parent
and Merger Sub shall promptly furnish to the Company all
information concerning Parent and Merger Sub that is required or
reasonably requested by Company in connection with the obligations
relating to the Schedule 14D-9 contained in this Section
1.02(b).
(c)
In connection with the Offer, the Company promptly
will furnish (or cause its transfer agent to furnish) Parent and
Merger Sub with mailing labels, security position listings and any
available listing or computer files containing the names and
addresses of the Company Stockholders, each as of a recent date,
and shall furnish Merger Sub with such additional information and
assistance (including updated lists of the Company Stockholders,
mailing labels and lists of securities positions) as Merger Sub or
its agents may reasonably request in communicating the Offer to the
record and beneficial holders of shares of Company Common
Stock. Except as required by applicable Law, and except as
necessary to communicate the Offer, the Merger or the transactions
contemplated by this Agreement to the Company Stockholders, Parent
and Merger Sub (and their respective representatives) shall hold in
confidence the information contained in any such labels, listings
and files, shall use such information solely in connection with the
Offer and the Merger, and, if this Agreement is terminated or the
Offer is otherwise terminated, shall promptly deliver or cause to
be delivered to the Company or destroy all copies of such
information, labels, listings and files then in their possession or
in the possession of their agents or representatives.
(d)
The Company hereby grants to Parent and Merger Sub
an irrevocable option (the " Merger Option ") to purchase up
to that number of newly issued shares of Company Common Stock (the
" Merger Option Shares ") equal to the number of shares of
Company Common Stock that, when added to the number of shares of
Company Common Stock owned by Parent and Merger Sub immediately
following consummation of the Offer, shall constitute one share
more than 90% of the shares of Company Common Stock then
outstanding on a fully diluted basis (after giving effect to the
issuance of the Merger Option Shares) for consideration per Merger
Option Share equal to the Offer Price.
(e)
The Merger Option shall be exercisable only after
the purchase of and payment for shares of Company Common Stock
pursuant to the Offer by Parent or Merger Sub as a result of which
Parent and Merger Sub own beneficially at least 80% of the
outstanding shares of Company Common Stock. The Merger Option
shall not be exercisable if the number of shares of Company Common
Stock subject thereto exceeds the number of authorized shares of
Company Common Stock available for issuance.
(f)
In the event that Parent or Merger Sub wish to
exercise the Merger Option, Merger Sub shall give the Company one
day’s prior written notice specifying the number of shares of
Company Common Stock that are or will be owned by Parent and Merger
Sub immediately following consummation of the Offer and specifying
a place and a time for the
4
closing of the purchase. The Company shall,
as soon as practicable following receipt of such notice, deliver
written notice to Merger Sub specifying the number of Merger Option
Shares. At the closing of the purchase of the Merger Option
Shares, the portion of the purchase price owing upon exercise of
the Merger Option that equals the product of (i) the number of
shares of Company Common Stock purchased pursuant to the Merger
Option, multiplied by (ii) the Offer Price, shall be paid to the
Company, at the election of Parent and Merger Sub, in cash (by wire
transfer or cashier’s check) or by delivery of a promissory
note having full recourse to Parent.
SECTION 1.03. Board of Directors .
(a)
Subject to compliance with applicable Law, promptly
upon the acceptance for payment of any shares of Company Common
Stock by Parent or Merger Sub or any of their affiliates pursuant
to and in accordance with the terms of the Offer (the "
Appointment Time ") and from time to time thereafter, and
subject to Section 1.03(c), Merger Sub shall be entitled to
designate up to such number of directors, rounded to the nearest
whole number constituting at least a majority of the directors, on
the Board of Directors of the Company as will give Merger Sub
representation on the Board of Directors of the Company equal to
the product of the number of directors on the Board of Directors of
the Company (giving effect to any increase in the number of
directors pursuant to this Section 1.03) and the percentage that
such number of shares of Company Common Stock beneficially owned by
Parent or its Affiliates bears to the total number of shares of
Company Common Stock then outstanding, and the Company shall use
reasonable best efforts to, upon Parent’s request, promptly,
at Parent’s election, either increase the size of the Board
of Directors of the Company or seeking and accepting the
resignation of such number of directors as is necessary to enable
Parent’s designees to be elected to the Board of Directors of
the Company and to cause Parent’s designees to be so
elected. At such times, subject to Section 1.03(c), the
Company will cause individuals designated by Parent to constitute
the number of members of each committee of the Board of Directors
of the Company, rounded up to the next whole number, that
represents the same percentage as such individuals represent on the
Board of Directors of the Company, other than any committee of the
Board of Directors of the Company established to take action under
this Agreement which committee shall be composed only of
Independent Directors (as defined in Section 1.03(c)).
(b)
The Company’ obligation to appoint designees
to the Board of Directors of the Company shall be subject to
Section 14(f) of the Exchange Act and Rule 14f-1 thereunder.
The Company shall promptly take all action required pursuant to
Section 14(f) of the Exchange Act and Rule 14f-1 thereunder in
order to fulfill its obligations under this Section 1.03, and shall
include in the Schedule 14D-9 such information with respect to the
Company and its officers and directors as is required pursuant to
such Section 14(f) of the Exchange Act and Rule 14f-1 thereunder in
order to fulfill its obligations under this Section 1.03 and the
U.S. federal securities laws. Parent shall provide to the
Company, and shall be solely responsible for, the information and
consents with respect to Parent and its designees, officers,
directors and affiliates required by Section 14(f) of the Exchange
Act and Rule 14f-1 thereunder.
(c)
In the event that Parent’s designees are
elected or designated to the Board of Directors of the Company,
then, until the Effective Time, the Company shall cause the Board
of Directors of the Company to have at least two directors who are
(i) directors on the date of this Agreement,
(ii) independent directors for purposes of the continued
listing requirements of
5
the New York Stock Exchange (the " NYSE ")
and (iii) reasonably satisfactory to Parent (such directors,
the " Independent Directors "); provided, however ,
that, if any Independent Director is unable to serve due to death
or disability or any other reason, the remaining Independent
Directors shall be entitled to elect or designate another
individual (or individuals) who serve(s) as a director (or
directors) on the date of this Agreement ( provided that no
such individual is an employee of Company or its subsidiaries) to
fill the vacancy, and such director (or directors) shall be deemed
to be an Independent Director (or Independent Directors) for
purposes of this Agreement. If no Independent Director
remains prior to the Effective Time, a majority of the members of
the Board of Directors of the Company at the time of the execution
of this Agreement shall be entitled to designate two persons to
fill such vacancies; provided that such individuals shall
not be employees or officers of the Company, Parent or Merger Sub
and shall be reasonably satisfactory to Parent, and such persons
shall be deemed Independent Directors for purposes of this
Agreement. Following the Appointment Time and prior to the
Effective Time, Parent and Merger Sub shall cause any amendment or
termination of this Agreement, any extension by the Company of the
time for the performance of any of the obligations or other acts of
Merger Sub or Parent or waiver of any of the Company’ rights
under this Agreement or other action adversely affecting the rights
of the Company Stockholders (other than Parent or Merger Sub), not
to be effected without the affirmative vote of a majority of the
Independent Directors. Following the Appointment Time and
prior to the Effective Time, neither Parent nor Merger Sub shall
take any action to remove any Independent Director absent
cause.
ARTICLE II
THE MERGER; EFFECT OF THE MERGER ON THE CAPITAL STOCK OF THE
CONSTITUENT CORPORATIONS; EXCHANGE OF CERTIFICATES
SECTION 2.01. The Merger . Upon
the terms and subject to the conditions set forth in this
Agreement, and in accordance with the DGCL, Merger Sub shall be
merged with and into the Company at the Effective Time. As a
result of the Merger, the separate corporate existence of Merger
Sub shall cease and the Company shall continue as the surviving
corporation of the Merger (the " Surviving Corporation
").
SECTION 2.02. Closing . The
closing of the Merger (the " Closing ") shall take place at
10:00 a.m., local time, on a date to be specified by the parties,
which shall be no later than the second Business Day after
satisfaction or (to the extent permitted by applicable Law) waiver
of the conditions set forth in Article VI (other than those
conditions that by their terms are to be satisfied at the Closing,
but subject to the satisfaction or (to the extent permitted by
applicable Law) waiver of those conditions), at the offices of
Wachtell, Lipton, Rosen & Katz, 51 West 52 nd Street, New York, New York
10019, unless another time, date or place is agreed to in writing
by Parent and the Company. The date on which the Closing
occurs is referred to in this Agreement as the " Closing
Date ".
SECTION 2.03. Effective Time .
Subject to the provisions of this Agreement, at the Closing, the
parties shall cause the Merger to be consummated by filing with the
Secretary of State of the State of Delaware a certificate of merger
(the " Certificate of Merger "), in such form as required
by, and executed and acknowledged by the parties in accordance
with, the relevant provisions of the DGCL, and shall make all other
filings or recordings required under the DGCL
6
in connection with the Merger. The Merger
shall become effective upon the filing of the Certificate of Merger
with the Secretary of State of the State of Delaware or at such
later time as Parent and the Company shall agree and shall specify
in the Certificate of Merger (the time the Merger becomes effective
being hereinafter referred to as the " Effective Time
").
SECTION 2.04. Effects of the Merger
. The Merger shall have the effects set forth herein and in
the applicable provisions of the DGCL. Without limiting the
generality of the foregoing and subject thereto, at the Effective
Time, all the property, rights, privileges, immunities, powers and
franchises of the Company and Merger Sub shall vest in the
Surviving Corporation and all debts, liabilities and duties of the
Company and Merger Sub shall become the debts, liabilities and
duties of the Surviving Corporation.
SECTION 2.05. Certificate of Incorporation
and By-laws . (a) The Restated Certificate of
Incorporation of the Company (the " Company Certificate ")
shall be amended at the Effective Time so that it is in
substantially the form as set forth on Exhibit A hereto
(with such changes or modifications as the Company and Parent may
agree) and, as so amended, such Company Certificate shall be the
certificate of incorporation of the Surviving Corporation until
thereafter changed or amended as provided therein and by applicable
Law.
(b)
At the Effective Time, and without any further
action on the part of the Company and Merger Sub, the Bylaws of
Merger Sub, as in effect immediately prior to the Effective Time,
shall be the Bylaws of the Surviving Corporation until thereafter
changed or amended as provided therein or by applicable
Law.
SECTION 2.06. Directors of the Surviving
Corporation . The directors of Merger Sub immediately
prior to the Effective Time shall be the directors of the Surviving
Corporation until the earlier of their resignation or removal or
until their respective successors are duly elected and qualified,
as the case may be.
SECTION 2.07. Officers of the Surviving
Corporation . The officers of the Company immediately
prior to the Effective Time shall be the initial officers of the
Surviving Corporation, each to hold office until the earlier of
their resignation or removal or until their respective successors
are duly elected and qualified, as the case may be.
SECTION 2.08. Additional Actions
. If, at any time after the Effective Time, the Surviving
Corporation shall consider or be advised that any further deeds,
assignments or assurances in law or any other acts are necessary or
desirable to (a) vest, perfect or confirm, of record or otherwise,
in the Surviving Corporation its right, title or interest in, to or
under any of the rights, properties or assets of the Company or (b)
otherwise carry out the provisions of this Agreement, the Company
and its officers and directors shall be deemed to have granted to
the Surviving Corporation an irrevocable power of attorney to
execute and deliver all such deeds, assignments or assurances in
law and to take all acts necessary, proper or desirable to vest,
perfect or confirm title to and possession of such rights,
properties or assets in the Surviving Corporation and otherwise to
carry out the provisions of this Agreement, and the officers and
directors of the Surviving Corporation are authorized in the name
of the Company or otherwise to take any and all such action.
7
SECTION 2.09. Effect on
Capital Stock . At the Effective Time, by virtue of the
Merger and without any action on the part of the holder of any
shares of Company Common Stock, or any shares of capital stock of
Parent or Merger Sub:
(a)
Capital Stock of Merger Sub . Each
issued and outstanding share of capital stock of Merger Sub shall
be converted into and become one validly issued, fully paid and
nonassessable share of common stock of the Surviving
Corporation.
(b)
Cancellation of Treasury Stock and Parent-Owned
Stock . Each share of Company Common Stock that is
directly owned by the Company, Parent or Merger Sub immediately
prior to the Effective Time shall automatically be canceled and
shall cease to exist, and no consideration shall be delivered in
exchange therefor. Any shares of Company Common Stock that
are owned by a wholly owned Subsidiary of the Company shall remain
outstanding after the Effective Time, appropriately adjusted such
that such Subsidiary owns the same percentage of the Company after
the Merger as it owned immediately prior to the Merger.
(c)
Merger Consideration . Each share of
Company Common Stock issued and outstanding immediately prior to
the Effective Time (other than shares to be canceled in accordance
with Section 2.09(b) and any Dissenting Shares) shall be converted
into the right to receive an amount of cash, without interest,
equal to the Offer Price (the " Merger Consideration
"). At the Effective Time, all such shares of Company Common
Stock shall no longer be outstanding and shall automatically be
canceled and shall cease to exist, and each holder of a certificate
which immediately prior to the Effective Time represented any such
shares of Company Common Stock (each, a " Certificate ")
shall cease to have any rights with respect thereto, except the
right to receive the Merger Consideration paid in consideration
therefor upon surrender of such Certificate in accordance with
Section 2.10(b), without interest. The right of any holder of
a Certificate to receive the Merger Consideration shall be subject
to and reduced by the amount of any withholding that is required
under applicable Tax Law.
(d)
Dissenting Shares .
-
-
(i)
Shares of Company Common Stock that are issued and
outstanding immediately prior to the Effective Time and which are
held by holders who have not voted in favor of or consented to the
Merger and who have properly demanded and perfected their rights to
be paid the fair value of such shares of Company Common Stock in
accordance with Section 262 of the DGCL (the " Dissenting
Shares ") shall not be canceled and the holder thereof shall
not receive the Merger Consideration as compensation for such
cancellation, and the holders thereof shall be entitled to only
such rights as are granted by Section 262 of the DGCL; provided,
however , that if any such stockholder of the Company shall
fail to perfect or shall effectively waive, withdraw or lose such
stockholder’s rights under Section 262 of the DGCL, such
stockholder’s Dissenting Shares in respect of which the
stockholder would otherwise be entitled to receive fair value under
Section 262 of the DGCL shall thereupon be deemed to have been
canceled, at the Effective Time, and the holder thereof shall be
entitled to receive the Merger Consideration (payable without any
interest thereon) as compensation for such cancellation.
8
-
-
(ii)
The Company shall give Parent (A) prompt notice of
any notice received by the Company of intent to demand the fair
value of any shares of Company Common Stock, withdrawals of such
notices and any other instruments or notices served pursuant to
Section 262 of the DGCL and (B) the opportunity to direct all
negotiations and proceedings with respect to the exercise of
appraisal rights under Section 262 of the DGCL. The Company
shall not, except with the prior written consent of Parent or as
otherwise required by an order, decree, ruling or injunction of a
court of competent jurisdiction, make any payment or other
commitment with respect to any such exercise of appraisal rights or
offer to settle or settle any such rights.
SECTION 2.10. Exchange of Certificates
. (a) Exchange Agent . Prior to the
Effective Time, Parent shall appoint a bank or trust company that
is reasonably satisfactory to the Company to act as exchange agent
(the " Exchange Agent ") for the payment of the Merger
Consideration. At the Effective Time, Parent shall deposit,
or cause the Surviving Corporation to deposit, with the Exchange
Agent, for the benefit of the holders of Certificates, cash in an
amount sufficient to pay the aggregate Merger Consideration
required to be paid pursuant to Section 2.09(c). Any funds
deposited with the Exchange Agent pursuant to this Section 2.10(a)
shall hereinafter be referred to as the " Exchange Fund
."
(b)
Exchange Procedures . As soon as
reasonably practicable after the Effective Time, Parent shall cause
the Exchange Agent to mail to each holder of record of a
Certificate whose shares of Company Common Stock were converted
into the right to receive the Merger Consideration (i) a form of
letter of transmittal (which shall specify that delivery shall be
effected, and risk of loss and title to the Certificates shall
pass, only upon proper delivery of the Certificates to the Exchange
Agent and which shall be in customary form and contain customary
provisions) and (ii) instructions for use in effecting the
surrender of the Certificates in exchange for the Merger
Consideration. Each holder of record of one or more
Certificates shall, upon surrender to the Exchange Agent of such
Certificate or Certificates, together with such letter of
transmittal, duly executed, and such other documents as may
reasonably be required by the Exchange Agent, be entitled to
receive in exchange therefor the amount of cash to which such
holder is entitled pursuant to Section 2.09(c), and the
Certificates so surrendered shall forthwith be canceled. In
the event of a transfer of ownership of Company Common Stock which
is not registered in the transfer records of the Company, payment
of the Merger Consideration in accordance with this Section 2.10(b)
may be made to a person other than the person in whose name the
Certificate so surrendered is registered if such Certificate shall
be properly endorsed or otherwise be in proper form for transfer
and the person requesting such payment shall pay any transfer Taxes
required by reason of the payment of the Merger Consideration to a
person other than the registered holder of such Certificate or
establish to the reasonable satisfaction of Parent that such Taxes
have been paid or are not applicable. Until surrendered as
contemplated by this Section 2.10(b), each Certificate shall be
deemed at any time after the Effective Time to represent only the
right to receive upon such surrender the Merger
Consideration. No interest shall be paid or will accrue on
any payment to holders of Certificates pursuant to the provisions
of this Article II.
(c)
No Further Ownership Rights in Company Common
Stock . The Merger Consideration paid upon the
surrender of Certificates in accordance with the terms of this
Article II shall be deemed to have been paid in full satisfaction
of all rights pertaining to the shares of
9
Company Common Stock formerly represented by such
Certificates. At the close of business on the day on which
the Effective Time occurs, the share transfer books of the Company
shall be closed, and there shall be no further registration of
transfers on the share transfer books of the Surviving Corporation
of the shares of Company Common Stock that were outstanding
immediately prior to the Effective Time. If, after the
Effective Time, any Certificate is presented to the Surviving
Corporation for transfer, it shall be canceled against delivery of
the Merger Consideration to the holder thereof as provided in this
Article II.
(d)
Termination of the Exchange Fund .
Any portion of the Exchange Fund which remains undistributed to the
holders of the Certificates for six months after the Effective Time
shall be delivered to Parent, upon demand, and any holders of the
Certificates who have not theretofore complied with this Article II
shall thereafter look only to Parent for, and Parent shall remain
liable for, payment of their claim for the Merger Consideration in
accordance with this Article II.
(e)
No Liability . None of Parent,
Merger Sub, the Company, the Surviving Corporation or the Exchange
Agent shall be liable to any person in respect of any funds from
the Exchange Fund properly delivered to a public official pursuant
to any applicable abandoned property, escheat or similar Law.
If any Certificate shall not have been surrendered prior to four
years after the Effective Time (or immediately prior to such
earlier date on which any Merger Consideration would otherwise
escheat to or become the property of any Governmental Entity), any
such Merger Consideration shall, to the extent permitted by
applicable Law, become the property of Parent, free and clear of
all claims or interest of any person previously entitled
thereto.
(f)
Investment of Exchange Fund . The
Exchange Agent shall invest the cash in the Exchange Fund as
directed by Parent. Any interest and other income resulting
from such investments shall be paid to and be income of
Parent. If for any reason (including losses) the cash in the
Exchange Fund shall be insufficient to fully satisfy all of the
payment obligations to be made in cash by the Exchange Agent
hereunder, Parent shall promptly deposit cash into the Exchange
Fund in an amount which is equal to the deficiency in the amount of
cash required to fully satisfy such cash payment
obligations.
(g)
Lost Certificates . If any
Certificate shall have been lost, stolen or destroyed, upon the
making of an affidavit of that fact by the person claiming such
Certificate to be lost, stolen or destroyed and, if required by
Parent, the posting by such person of a bond in such reasonable
amount as Parent may direct as indemnity against any claim that may
be made against it with respect to such Certificate, the Exchange
Agent shall deliver in exchange for such lost, stolen or destroyed
Certificate the Merger Consideration pursuant to this Article
II.
(h)
Withholding Rights . Parent, the
Surviving Corporation or the Exchange Agent shall be entitled to
deduct and withhold from the consideration otherwise payable
pursuant to this Agreement such amounts as Parent, the Surviving
Corporation or the Exchange Agent are required to deduct and
withhold with respect to the making of such payment under the
Internal Revenue Code of 1986, as amended (the " Code "), or
any provision of state, local or foreign Tax Law. To the
extent that amounts are so withheld and paid over to the
appropriate Taxing Authority by Parent, the Surviving Corporation
or the Exchange Agent, such withheld amounts
10
shall be treated for all purposes of this
Agreement as having been paid to the holder of Certificates in
respect of which such deduction and withholding was made by Parent,
the Surviving Corporation or the Exchange Agent.
ARTICLE III
REPRESENTATIONS AND WARRANTIES
SECTION 3.01. Representations and
Warranties of the Company . Except as set forth in the
disclosure schedule delivered by the Company to Parent prior to the
execution of this Agreement (the " Company Disclosure
Schedule ") (with specific reference to the particular Section
or subsection of this Agreement to which the information set forth
in such disclosure schedule relates), the Company represents and
warrants to Parent and Merger Sub as follows:
(a)
Organization, Standing and Corporate Power
. The Company and each of its Subsidiaries has been duly
organized, and is validly existing and in good standing (with
respect to jurisdictions that recognize that concept) under the
Laws of the jurisdiction of its incorporation or formation, as the
case may be, and has all requisite power and authority and
possesses all governmental licenses, permits, authorizations and
approvals necessary to enable it to use its corporate or other name
and to own, lease or otherwise hold and operate its properties and
other assets and to carry on its business as currently conducted,
except where the failure to have such governmental licenses,
permits, authorizations or approvals individually or in the
aggregate has not had and would not reasonably be expected to have
a Material Adverse Effect. The Company and each of its
Subsidiaries is duly qualified or licensed to do business and is in
good standing (with respect to jurisdictions that recognize that
concept) in each jurisdiction in which the nature of its business
or the ownership, leasing or operation of its properties makes such
qualification, licensing or good standing necessary, other than in
such jurisdictions where the failure to be so qualified, licensed
or in good standing individually or in the aggregate has not had
and would not reasonably be expected to have a Material Adverse
Effect. The Company has made available to Parent, prior to
the date of this Agreement, complete and accurate copies of the
Company Certificate and the Company’s Bylaws (the "
Company Bylaws "), and the comparable organizational
documents of each significant subsidiary (as such term is defined
in Rule 12b-2 under the Exchange Act, a " Significant
Subsidiary "), in each case as amended to the date
hereof.
(b)
Subsidiaries . Section 3.01(b)(i) of
the Company Disclosure Schedule lists, as of the date hereof, (i)
each Significant Subsidiary of the Company (including its state of
incorporation or formation) and (ii) each other Subsidiary of the
Company. All of the outstanding capital stock of, or other
equity interests in, each Significant Subsidiary of the Company, is
directly or indirectly owned by the Company. All the issued
and outstanding shares of capital stock of, or other equity
interests in, each such Subsidiary owned by the Company have been
validly issued and are fully paid and nonassessable and are owned
directly or indirectly by the Company free and clear of all
pledges, liens, charges, encumbrances or security interests of any
kind or nature whatsoever (other than liens, charges and
encumbrances for current Taxes not yet due and payable)
(collectively, " Liens "), and free of any restriction on
the right to vote, sell or otherwise dispose of such capital stock
or other equity or similar interests. Except as listed on
Section 3.01(b)(ii) of the Company Disclosure Schedule, the Company
does not own, directly or indirectly, as of the date hereof, any
capital stock of, or other voting
11
securities or equity or similar interests in, any
corporation, partnership, joint venture, association, limited
liability company or other entity or person.
(c)
Capital Structure; Indebtedness .
The authorized capital stock of the Company consists of 100,000,000
shares of Company Common Stock and 5,000,000 shares of preferred
stock, par value $0.01 per share (" Company Preferred Stock
"). At the close of business on May 8, 2007:
-
-
(i)
33,340,002 shares of Company Common Stock were
issued and outstanding, and 60,672 shares of Company Common Stock
were held by the Company in its treasury;
(ii)
3,548,271 shares of Company Common Stock were
subject to issuance upon exercise of outstanding Company Stock
Options under the Company’s Equity Incentive Plan, as amended
prior to the date of this Agreement (the " Company Stock
Plan "), (ii) 225,352 shares of Company Common Stock were
subject to issuance pursuant to outstanding restricted stock units
granted under the Company Stock Plan (the " Company Restricted
Stock Units "), (iii) 78,000 shares of Company Common Stock
were subject to issuance pursuant to outstanding deferred stock
awards granted under the Company Stock Plan (the " Company
Director Stock Units "), (iv) 1,583,641 shares of Company
Common Stock were reserved for future grant and issuance under the
Company Stock Plan (excluding shares subject to issuance pursuant
to outstanding Company Stock Options, Company Restricted Stock
Units and Company Director Stock Units) and (v) 231,872 shares of
Company Common Stock were reserved for future issuance under the
Company’s Employee Stock Purchase Plan, as amended to date
(the " Company ESPP ");
(iii)
no shares of Company Preferred Stock were issued or
outstanding or were held by the Company as treasury shares or were
reserved for issuance;
(iv)
except as set forth above in this Section 3.01(c),
at the close of business on May 8, 2007, no shares of capital stock
or other voting securities or equity interests of the Company were
issued, reserved for issuance or outstanding. No Subsidiary
of the Company owns, holds or has any interest in shares of Company
Common Stock. Except as set forth above in this Section
3.01(c), at the close of business on May 8, 2007, there were no
outstanding stock appreciation rights, "phantom" stock rights,
performance units, rights to receive shares of Company Common Stock
on a deferred basis or other rights that are linked to the value of
Company Common Stock (collectively, " Company Stock-Based
Awards "). All outstanding options to purchase shares of
Company Common Stock (collectively, " Company Stock Options
"), are evidenced by stock option agreements or other award
agreements in the forms previously provided to Parent. All
outstanding shares of capital stock of the Company are, and all
shares which may be issued pursuant to the Company Stock Options,
Company Restricted Stock Units, Company Director Stock Units and
the Company ESPP will be, when issued in accordance with the terms
thereof, duly authorized, validly issued, fully paid and
nonassessable and not subject to preemptive rights. There are
no bonds, debentures, notes or other indebtedness of the Company
having the right to vote (or
12
-
-
convertible into, or exchangeable for, securities
having the right to vote) on any matters on which stockholders of
the Company may vote. Except as set forth above in this
Section 3.01(c) and for issuances of shares of Company Common Stock
pursuant to the Company Stock Options, Company Restricted Stock
Units, Company Director Stock Units and the Company ESPP (and with
respect to changes to the following after the date of this
Agreement, only such changes in accordance with Section 4.01(a)):
(x) there are not issued, reserved for issuance or outstanding (A)
any shares of capital stock or other voting securities or equity
interests of the Company, (B) any securities of the Company
convertible into or exchangeable or exercisable for shares of
capital stock or other voting securities or equity interests of the
Company, (C) any warrants, calls, options or other rights to
acquire from the Company or any of its Subsidiaries, and, except
for the Merger Option granted in this Agreement, no obligation of
the Company or any of its Subsidiaries to issue, any capital stock,
voting securities, equity interests or securities convertible into
or exchangeable or exercisable for capital stock or voting
securities of the Company or (D) any Company Stock-Based
Awards and (y) there are not any outstanding obligations of the
Company or any of its Subsidiaries to repurchase, redeem or
otherwise acquire any such securities or to issue, deliver or sell,
or cause to be issued, delivered or sold, any such
securities. Neither the Company nor any of its Subsidiaries
is a party to any voting Contract with respect to the voting of any
such securities. Except as set forth above in this Section
3.01(c) and subject to Section 4.01(a), there are no outstanding
(1) securities of the Company or any of its Subsidiaries
convertible into or exchangeable or exercisable for shares of
capital stock or voting securities or equity interests of any
Subsidiary of the Company, (2) warrants, calls, options or other
rights to acquire from the Company or any of its Subsidiaries, and
no obligation of the Company or any of its Subsidiaries to issue,
any capital stock, voting securities, equity interests or
securities convertible into or exchangeable or exercisable for
capital stock or voting securities of any Subsidiary of the Company
or (3) obligations of the Company or any of its Subsidiaries to
repurchase, redeem or otherwise acquire any such outstanding
securities or to issue, deliver or sell, or cause to be issued,
delivered or sold, any such securities; and
(v)
the only principal amount of outstanding
indebtedness for borrowed money of the Company and its Subsidiaries
(not including intercompany amounts or operating or capital leases)
is (A) $40,475,000 (which amount is as of the close of business on
May 9, 2007) under the Company’s Credit Agreement, dated as
of May 3, 2005 with certain lenders and agents named therein, as
amended prior to the date of this Agreement, and (B) other
indebtedness for borrowed money in an aggregate principal amount
not to exceed $15 million.
The per share exercise price of each Company Stock Option is
equal to or greater than the fair market value of the underlying
Company Common Stock determined as prescribed by the applicable
Company Stock Plan on the effective date of the corporate action
effectuating the grant of such Company Stock-Based Award or Company
Stock Option, as applicable. From and after May 8, 2007,
neither the Company nor any of its Subsidiaries has issued any
shares of Company Common Stock or any securities convertible into
or exercisable for any shares of Company Common Stock, other than
the issuance of Company Common Stock upon the exercise of Company
Stock Options, Company Restricted Stock Units, Company Director
Stock Units or
13
other Company Stock-Based Awards outstanding as
of May 8, 2007 in accordance with their terms as of May 8,
2007.
(d)
Authority; Noncontravention . The
Company has all requisite corporate power and authority to execute
and deliver this Agreement and, subject to receipt of the Company
Stockholder Approval if required by applicable Law to consummate
the Merger, to consummate the transactions contemplated by this
Agreement. The execution and delivery of this Agreement by
the Company and the consummation by the Company of the transactions
contemplated by this Agreement have been duly authorized by all
necessary corporate action on the part of the Company and no other
corporate proceedings on the part of the Company are necessary to
authorize this Agreement or to consummate the transactions
contemplated by this Agreement (other than the obtaining of the
Company Stockholder Approval for the Merger, if required by
applicable Law). This Agreement has been duly executed and
delivered by the Company and, assuming the due authorization,
execution and delivery by each of the other parties hereto,
constitutes a legal, valid and binding obligation of the Company,
enforceable against the Company in accordance with its terms.
The Board of Directors of the Company has unanimously, by
resolutions duly adopted at a meeting duly called and held (i)
approved this Agreement, and declared this Agreement, the Offer,
the Merger and the transactions contemplated by this Agreement
advisable, fair to and in the best interests of the Company and the
Company Stockholders, and (ii) resolved to recommend that the
Company Stockholders accept the Offer, that the Company
Stockholders tender their shares of Company Common Stock in the
Offer to Merger Sub, and that the Company Stockholders approve and
adopt this Agreement and the Merger to the extent required by
applicable Law. Subject to Section 4.02, the Board of
Directors has not rescinded, modified or withdrawn such resolutions
in any way. The execution and delivery of this Agreement by
the Company do not, and the consummation by the Company of the
Offer and the Merger and the other transactions contemplated by
this Agreement and compliance by the Company with the provisions of
this Agreement will not, conflict with, or result in any violation
or breach of, or default (with or without notice or lapse of time,
or both) under, or give rise to a right of, or result in,
termination, modification, cancellation or acceleration of any
obligation or to the loss of a benefit under, or result in the
creation of any Lien in or upon any of the properties or other
assets of the Company or any of its Subsidiaries under, (x) the
Company Certificate or the Company Bylaws or the comparable
organizational documents of any of its Subsidiaries, (y) any loan
or credit agreement, bond, debenture, note, mortgage, indenture,
lease, supply agreement, license agreement, development agreement
or other contract, agreement, obligation, commitment or instrument
(each, including all amendments thereto, a " Contract "), to
which the Company or any of its Subsidiaries is a party or any of
their respective properties or other assets is subject or (z)
subject to the obtaining of the Company Stockholder Approval if
required by applicable Law and the governmental filings and other
matters referred to in the following sentence, any (A) statute,
law, ordinance, rule or regulation (domestic or foreign) issued,
promulgated or entered into by or with any Governmental Entity
(each, a " Law ") applicable to the Company or any of its
Subsidiaries or any of their respective properties or other assets
or (B) order, writ, injunction, decree, judgment or stipulation
issued, promulgated or entered into by or with any Governmental
Entity (each, an " Order ") applicable to the Company or any
of its Subsidiaries or their respective properties or other assets,
other than, in the case of clauses (y) and (z), any such conflicts,
violations, breaches, defaults, rights of termination,
modification, cancellation or acceleration, losses or Liens that
individually or in the aggregate have not had and would not
reasonably be expected to (A) have a
14
Material Adverse Effect, (B) impair in any
material respect the ability of the Company to perform its
obligations under this Agreement or (C) prevent or materially
impede, interfere with, hinder or delay the consummation of any of
the transactions contemplated by this Agreement. No consent,
approval, order or authorization of, action by or in respect of, or
registration, declaration or filing with, any Federal, state, local
or foreign government, any court, administrative, regulatory or
other governmental agency, commission or authority or any organized
securities exchange (each, a " Governmental Entity ") is
required by or with respect to the Company or any of its
Subsidiaries in connection with the execution and delivery of this
Agreement by the Company or the consummation of the Offer, the
Merger or the other transactions contemplated by this Agreement,
except for (1) (A) the filing of a premerger notification and
report form by the Company under the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended, and the rules and regulations
thereunder (the " HSR Act ") and the termination of the
waiting period required thereunder and (B) the receipt, termination
or expiration, as applicable, of approvals or waiting periods
required under any other applicable Antitrust Law, (2) applicable
requirements of the Exchange Act, and state securities takeover and
"blue sky" laws, as may be required in connection with this
Agreement and the transactions contemplated by this Agreement, (3)
the filing of the Certificate of Merger with the Secretary of State
of the State of Delaware, (4) any filings with and approvals of the
NYSE and (5) such other consents, approvals, orders,
authorizations, actions, registrations, declarations and filings
the failure of which to be obtained or made individually or in the
aggregate has not had and would not reasonably be expected to (x)
have a Material Adverse Effect, (y) impair in any material respect
the ability of the Company to perform its obligations under this
Agreement or (z) prevent or materially impede, interfere with,
hinder or delay the consummation of any of the transactions
contemplated by this Agreement.
(e)
Company SEC Documents .
-
-
(i)
The Company has timely filed all reports, schedules,
forms, statements and other documents (including exhibits and other
information incorporated therein) with the SEC required to be filed
by the Company since January 1, 2004 (such documents, together with
any documents filed during such period by the Company to the SEC on
a voluntary basis on Current Reports on Form 8-K, the " Company
SEC Documents "). As of their respective filing dates,
the Company SEC Documents complied in all material respects with,
to the extent in effect at the time of filing, the requirements of
the U.S. Securities Act of 1933, as amended (including the rules
and regulations promulgated thereunder, the " Securities Act
"), the Exchange Act and the Sarbanes-Oxley Act of 2002 (including
the rules and regulations promulgated thereunder, " SOX ")
applicable to such Company SEC Documents. Except to the
extent that information contained in any Company SEC Document has
been revised, amended, supplemented or superseded by a later-filed
Company SEC Document that has been filed prior to the date of this
Agreement, as of their respective filing dates, none of the Company
SEC Documents contains any untrue statement of a material fact or
omits to state any material fact required to be stated therein or
necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading, which
individually or in the aggregate would require an amendment,
supplement or correction to such Company SEC Documents. Each
of the financial statements (including the related notes) of the
Company included in the Company SEC
15
-
-
Documents complied at the time it was filed as to
form in all material respects with the applicable accounting
requirements and the published rules and regulations of the SEC
with respect thereto in effect at the time of such filing, had been
prepared in accordance with generally accepted accounting
principles in the United States (" GAAP ") (except, in the
case of unaudited statements, as permitted by the rules and
regulations of the SEC) applied on a consistent basis during the
periods involved (except as may be indicated in the notes thereto)
and fairly presented in all material respects the consolidated
financial position of the Company and its consolidated Subsidiaries
as of the dates thereof and the consolidated results of their
operations and cash flows for the periods then ended (subject, in
the case of unaudited statements, to normal year-end audit
adjustments). None of the Subsidiaries of the Company are, or
have at any time since January 1, 2004 been, subject to the
reporting requirements of Section 13(a) or 15(d) of the Exchange
Act.
(ii)
Each of the principal executive officer of the
Company and the principal financial officer of the Company (or each
former principal executive officer of the Company and each former
principal financial officer of the Company, as applicable) has made
all certifications required by Rule 13a-14 or 15d-14 under the
Exchange Act and Sections 302 and 906 of SOX with respect to the
Company SEC Documents, and the statements contained in such
certifications are true and accurate. For purposes of this
Agreement, "principal executive officer" and "principal financial
officer" shall have the meanings given to such terms in SOX.
Neither the Company nor any of its Subsidiaries has outstanding
(nor has arranged or modified since the enactment of SOX) any
"extensions of credit" (within the meaning of Section 402 of SOX )
to directors or executive officers (as defined in Rule 3b-7 under
the Exchange Act) of the Company or any of its
Subsidiaries.
(iii)
The Company maintains a system of internal
accounting controls sufficient to provide reasonable assurance that
(A) transactions are executed in accordance with management’s
general or specific authorizations; (B) access to assets is
permitted only in accordance with management’s general or
specific authorization; and (C) the recorded accountability for
assets is compared with the existing assets at reasonable intervals
and appropriate action is taken with respect to any
differences.
(iv)
The Company’s "disclosure controls and
procedures" (as defined in Rules 13a-15(e) and 15d-15(e) of the
Exchange Act) are reasonably designed to ensure that all
information (both financial and non-financial) required to be
disclosed by the Company in the reports that it files or submits
under the Exchange Act is recorded, processed, summarized and
reported within the time periods specified in the rules and forms
of the SEC, and that all such information is accumulated and
communicated to the Company’s management as appropriate to
allow timely decisions regarding required disclosure and to make
the certifications of the chief executive officer and chief
financial officer of the Company required under the Exchange Act
with respect to such reports. The Company has disclosed,
based on its most recent evaluation of such disclosure controls and
procedures prior to the date of this Agreement, to the
Company’s auditors and the audit committee of the Board of
Directors of the Company and on 3.01(e)(iv) of the Company
Disclosure Schedule (A) any significant deficiencies and material
weaknesses in the design or operation of internal controls over
financial reporting that are
16
-
-
reasonably likely to adversely affect in any
material respect the Company’s ability to record, process,
summarize and report financial information and (B) any fraud,
whether or not material, that involves management or other
employees who have a significant role in the Company’s
internal controls over financial reporting.
(v)
Since December 31, 2005 through the date of this
Agreement, (i) neither the Company nor any of its Subsidiaries
nor, to the Knowledge of the Company, any director, officer,
employee, auditor, accountant or representative of the Company or
any of its Subsidiaries has received or otherwise had or obtained
knowledge of any material complaint, allegation, assertion or
claim, whether written or oral, regarding the accounting or
auditing practices, procedures, methodologies or methods of the
Company or any of its Subsidiaries or their respective internal
accounting controls, including any material complaint, allegation,
assertion or claim that the Company or any of its Subsidiaries has
engaged in questionable accounting or auditing practices, and (ii)
no attorney representing the Company or any of its Subsidiaries,
whether or not employed by the Company or any of its Subsidiaries,
has reported evidence of a material violation of securities Laws,
breach of fiduciary duty or similar violation by the Company or any
of its officers, directors, employees or agents to the Board of
Directors of the Company or any committee thereof or to any
director or officer of the Company.
(f)
Information Supplied . None of the
information supplied or to be supplied by or on behalf of the
Company specifically for inclusion or incorporation by reference in
the Offer Documents, the Schedule 14D-9 or the Proxy Statement
will, on the date that such document is first mailed to the
stockholders of the Company and during the pendency of the Offer
and the subsequent offering period, if any (in the case of the
Offer Documents and the Schedule 14D-9) and at the time of the
Company Stockholders’ Meeting, if any (in the case of the
Proxy Statement), contain any untrue statement of a material fact
or omit to state any material fact required to be stated therein or
necessary in order to make the statements therein, in light of the
circumstances under which they are made, not misleading, except
that no representation or warranty is made by the Company with
respect to statements made or incorporated by reference therein
based on information supplied by or on behalf of Parent or Merger
Sub specifically for inclusion or incorporation by reference in the
Offer Documents, the Schedule 14D-9 or the Proxy Statement.
The Schedule 14D-9 and the Proxy Statement will comply as to form
in all material respects with the requirements of the Exchange
Act.
(g)
Absence of Certain Changes or Events
. Except for liabilities incurred as a result of this
Agreement or, with respect to liabilities incurred after the date
hereof, as expressly permitted pursuant to Section 4.01(a), since
December 31, 2006, the Company and its Subsidiaries have conducted
their respective businesses only in the ordinary course consistent
with past practice, (i) there has not been any Material Adverse
Change, and (ii) from such date until the date hereof there has not
been (A) any declaration, setting aside or payment of any dividend
or other distribution (whether in cash, stock or property) with
respect to any capital stock of the Company or any of its
Subsidiaries, other than dividends or distributions by a direct or
indirect wholly owned Subsidiary of the Company to its
stockholders, (B) any purchase, redemption or other acquisition by
the Company or any of its Subsidiaries of any shares of capital
stock or any other securities of the Company or any of its
Subsidiaries or any options, warrants, calls or rights to acquire
such shares or other securities, including pursuant to the
17
Company’s share repurchase program, (C) any
split, combination or reclassification of any capital stock of the
Company or any of its Subsidiaries or any issuance or the
authorization of any issuance of any other securities in respect
of, in lieu of or in substitution for shares of their respective
capital stock, (D) (1) any granting by the Company or any of its
Subsidiaries to any current or former director, officer, employee
or independent contractor, of the Company or any of its
Subsidiaries (all such individuals, collectively, the " Company
Personnel ") of any increase in compensation, bonus or fringe
or other benefits, except in the ordinary course of business
consistent with past practice or as was required under any Company
Benefit Agreement or Company Benefit Plan, (2) any granting by the
Company or any of its Subsidiaries to any Company Personnel of (x)
any increase in severance or termination pay or (y) any right to
receive any severance or termination pay, (3) any entry by the
Company or any of its Subsidiaries into, or any amendments of, (x)
any employment, deferred compensation, consulting, severance,
change of control, termination, retention, deal bonus or
indemnification Contract with any Company Personnel or (y) any
Contract with any Company Personnel the benefits of which are
contingent, or the terms of which are materially altered, upon the
occurrence of a transaction involving the Company of a nature
contemplated by this Agreement (all Contracts of the type described
by this clause (3), collectively, " Company Benefit
Agreements "), (4) the removal or modification of any
restrictions in any Company Benefit Agreement or Company Benefit
Plan or awards made thereunder, except as required to comply with
applicable Law or any Company Benefit Agreement or Company Benefit
Plan in effect as of the date hereof, or (5) the adoption,
amendment or termination of any Company Benefit Plan or entry into
any agreement, plan or arrangement to do any of the foregoing, (E)
any material damage, destruction or loss, whether or not covered by
insurance, (F) any change in accounting methods, principles or
practices by the Company materially affecting its assets,
liabilities or businesses, except insofar as may have been required
by a change in GAAP, (G) any material Tax election or any
settlement or compromise of any material income Tax liability or
(H) any other action taken or committed to be taken by the Company
or any Subsidiary of the Company which, if taken following entry by
the Company into this Agreement, would have required the consent of
Parent pursuant to Section 4.01(a).
(h)
Litigation . There are no actions,
suits, claims, hearings, proceedings, arbitrations, mediations,
audits, inquiries or investigations (whether civil, criminal,
administrative or otherwise) (" Actions ") pending or, to
the Knowledge of the Company, threatened against the Company or any
of its Subsidiaries or any of the executive officers or directors
of the Company, except, in each case, for those that, individually
or in the aggregate, (A) have not had, and would not reasonably be
expected to have a Material Adverse Effect and (B) would not
reasonably be expected to prevent, materially delay or materially
impede the ability of the Company to consummate the Offer, the
Merger or the other transactions contemplated by this
Agreement. Neither the Company nor any of its Subsidiaries
nor any of their respective properties or assets is or are subject
to any Order, writ, judgment, injunction, settlement, decree or
award, except for those that, individually or in the aggregate, (x)
have not had, and would not reasonably be expected to have, a
Material Adverse Effect and (y) would not reasonably be expected to
prevent, materially delay or materially impede the ability of the
Company to consummate the Offer, the Merger or the other
transactions contemplated by this Agreement. Since January 1,
2004 there has not been any material product liability,
manufacturing or design defect, warranty, field repair or other
material product-related claims by any third party (whether based
on contract or tort and whether relating to personal
injury,
18
including death, property damage or economic
loss) arising from (A) services rendered by the Company or any of
its Subsidiaries or (B) the sale, distribution or manufacturing of
products by the Company or any of its Subsidiaries. To the
Knowledge of the Company (including for this purpose the members of
the Audit Committee of the Board of Directors of the Company),
there are no formal or informal governmental inquiries or
investigations or internal investigations or whistle-blower
complaints pending or threatened, in each case regarding accounting
or disclosure practices of the Company or any of its Subsidiaries,
compliance by the Company or any of its Subsidiaries with any Law
or any malfeasance by any officer of the Company or any of its
Subsidiaries.
(i)
Material Contracts .
-
-
(i)
Except for this Agreement, neither the Company nor
any of its Subsidiaries is a party to or bound by any contract,
arrangement, commitment or understanding (A) with respect to the
employment of any directors or executive officers of the Company,
(B) that is a "material contract" (as such term is defined in Item
601(b) (10) of Regulation S-K of the SEC), (C) that limits or
purports to limit in any material respect the ability of the
Company or any of its Affiliates to compete in any line of
business, in any geographic area or with any person, or that
requires referrals of any material amount of business of the
Company or any of its Affiliates, (D) with respect to any customer
or distribution agreements where the Company or any of its
Subsidiaries has received or expects to receive in the next twelve
(12) months $750,000 or more in receivables pursuant to such
agreements, (E) with respect to the receipt of any goods and
services involving a payment of $750,000 or more per annum (other
than those cancelable by the Company without penalty or notice of
180 days or less), (F) in the case of a Company Benefit Plan, any
of the benefits of which will be increased, or the vesting of the
benefits of which will be accelerated, by the occurrence of any of
the transactions contemplated by this Agreement, or the value of
any of the benefits of which will be calculated on the basis of any
of the transactions contemplated by this Agreement or (G) that
would prevent, materially delay or materially impede the
consummation of any of the transactions contemplated by this
Agreement. All contracts, arrangements, commitments or
understandings of the type described in this Section 3.01(i) shall
be collectively referred to herein as the " Material
Contracts ."
(ii)
Schedule 3.01(i) of the Company Disclosure Schedule
sets forth a list of all Material Contracts as of the date of this
Agreement. Each such Material Contract is valid and in full
force and effect and enforceable in accordance with its respective
terms, subject to applicable bankruptcy, insolvency,
reorganization, moratorium or other laws relating to or affecting
the rights and remedies of creditors generally and to general
principles of equity (regardless of whether considered in a
proceeding in equity or at law), except to the extent that (A) they
have previously expired in accordance with their terms or (B) the
failure to be in full force and effect, individually or in the
aggregate, has not had and would not reasonably be expected to have
a Material Adverse Effect. Neither the Company nor any of its
Subsidiaries, nor, to the Company’s Knowledge, any
counterparty to any Material Contract, has violated or is alleged
to have violated any provision of, or committed or failed to
perform any act which, with or without notice, lapse of time or
both, would constitute a default under the provisions of
19
-
-
any Material Contract, except in each case for
those violations and defaults which, individually or in the
aggregate, has not had and would not reasonably be expected to have
a Material Adverse Effect.
(j)
Compliance with Laws; Environmental
Matters .
-
-
(i)
Except for failures to be in compliance and failures
to have such Permits that individually or in the aggregate have not
had and would not reasonably be expected to have a Material Adverse
Effect: (A) each of the Company and its Subsidiaries is in
compliance with all, and has not violated any, Laws and Orders,
including the Federal Food, Drug and Cosmetic Act of 1938, as
amended (including the rules and regulations promulgated
thereunder, the " FDCA "), the Good Manufacturing Practices
and other standards of the Food and Drug Administration, federal
Medicare and Medicaid statutes or related state or local statutes
or regulations, and the Occupational Safety and Health Act (and the
regulations promulgated thereunder), the Fair Labor Standards Act
and any other applicable child labor Laws, all applicable
import/export Laws, the International Traffic in Arms Regulations
(22 C.F.R. §§120-130), and any comparable foreign Laws of
any of the foregoing, applicable to it, its properties or other
assets or its business or operations, including the Medical Devices
Directive of the European Union (the " MDD ") and (B) the
Company and each of its Subsidiaries has in effect all approvals,
authorizations, certificates, filings, franchises, licenses,
notices and permits of or with all Governmental Entities, including
all Permits under the FDCA and the MDD, and third persons
(collectively, " Permits ") necessary for it to own, lease
or operate its properties and other assets and to carry on its
business and operations as currently conducted. Neither the
Company nor any of its Subsidiaries is excluded from participation,
or is otherwise ineligible to participate, in a "federal health
care program" as defined in 42 U.S.C. §1320a-7b(f) or is
convicted of a criminal offense related to health care. Since
January 1, 2004, there has occurred no default under, or violation
of, any such Permit, except for any such default or violation that
individually or in the aggregate has not had and would not
reasonably be expected to have a Material Adverse Effect. The
consummation of the Offer or the Merger, in and of itself, would
not cause the revocation, modification or cancellation of any such
Permit that individually or in the aggregate would reasonably be
expected to have a Material Adverse Effect.
(ii)
Except for those matters that individually or in the
aggregate have not had and would not reasonably be expected to have
a Material Adverse Effect: (A) during the period of ownership or
operation by the Company or any of its Subsidiaries of any of its
currently or formerly owned, leased or operated properties or
facilities, there have been no Releases of Hazardous Materials in,
on, under, from or affecting any properties or facilities which
would subject the Company or any of its Subsidiaries to any
liability under any Environmental Law or require any expenditure by
the Company or any of its Subsidiaries thereunder; (B) prior to and
after, as applicable, the period of ownership or operation by the
Company or any of its Subsidiaries of any of its currently or
formerly owned, leased or operated properties or facilities, to the
Knowledge of the Company, there were no Releases of Hazardous
Materials in, on, under, from or affecting any properties or
facilities which would subject the Company or any of its
Subsidiaries to any liability under any Environmental Law or
require any expenditure by the Company
20
-
-
or any of its Subsidiaries thereunder; (C) none
of the Company or its Subsidiaries has Released Hazardous Materials
at any other location which would subject the Company or any of its
Subsidiaries to any liability under Environmental Law or require
any expenditure by the Company or any of its Subsidiaries
thereunder; (D) neither the Company nor any of its Subsidiaries is
subject to any indemnity obligation or other Contract with any
person relating to obligations or liabilities under Environmental
Laws; and (E) to the Knowledge of the Company, there are no facts,
circumstances or conditions that would reasonably be expected to
form the basis for any Action or liability against or affecting the
Company or any of its Subsidiaries relating to or arising under
Environmental Laws or that would interfere with or increase the
cost of complying with all applicable Environmental Laws in the
future.
(iii)
Except for those matters that individually or in the
aggregate have not had and would not reasonably be expected to have
a Material Adverse Effect:
-
-
-
-
(A)
to the Company’s Knowledge, there are no
adverse negative past performance evaluations or ratings by the
U.S. Government or any other Governmental Entity, or any voluntary
disclosures under the Foreign Corrupt Practices Act of 1977 (the "
Foreign Corrupt Practices Act ") or any other comparable
foreign Law, any enforcement actions or threats of enforcement
actions, or facts that, in each case, could result in any adverse
or negative performance evaluations related to the Foreign Corrupt
Practices Act or any other comparable foreign Law. Neither
the U.S. Government nor any other person has notified the Company
or any of its Subsidiaries in writing of any actual or alleged
violation or breach of the Foreign Corrupt Practices Act or any
other comparable foreign Law. To the Knowledge of the
Company, none of the Company and its Subsidiaries has undergone or
is undergoing any audit, review, inspection, investigation, survey
or examination of records relating to the Company’s or any of
its Subsidiaries’ compliance with the Foreign Corrupt
Practices Act or any other comparable foreign Law. To the
Knowledge of the Company, the Company and its Subsidiaries have not
been and are not now under any administrative, civil or criminal
investigation or indictment and are not party to any litigation
involving alleged false statements, false claims or other
improprieties relating to the Company’s or any of its
Subsidiaries’ compliance with the Foreign Corrupt Practices
Act or any other comparable foreign Law;
(B)
to the Company’s Knowledge, none of the
Company, any of its Subsidiaries or any of their employees is, or
since January 1, 2004, has been, in violation of any Law applicable
to its business, properties or operations and relating to: (1) the
use of corporate funds relating to political activity or for the
purpose of obtaining or retaining business; (2) payments to
government officials or employees from corporate funds; or (3)
bribes, rebates, payoffs, influence payments or kickbacks
(including 42 U.S.C. 1320 a-7b(b), as amended or any applicable
state anti-kickback or other similar state or federal
laws);
21
-
-
-
-
-
-
(C)
to the Company’s Knowledge, none of the
Company, any of its Subsidiaries or any of their officers,
directors, employees, independent contractors, suppliers and/or
agents have been convicted of, charged with or investigated for a
Medicare, Medicaid or state health program related offense or
convicted of, charged with or investigated for a violation of
federal or state law related to Medicare, Medicaid or any other
federal or state health care program, or been subject to any order
or consent decree of, or material criminal or civil fine or penalty
imposed by, any Governmental Entity with respect to any such
program; and
(D)
to the Company’s Knowledge, neither the
Company nor any of its Subsidiaries has arranged or contracted with
(by employment or otherwise) any individual that is excluded from
participation in a Federal Health Care Program as defined in 42
U.S.C.1320a-7b(f) for the provision of items or services for which
payment may be made under such Federal Health Care
Program.
(k)
Labor Relations and Other Employment
Matters .
-
-
(i)
Since December 31, 2006, there has not been any
adoption, amendment or termination by the Company or any of its
Subsidiaries of any collective bargaining or other labor union
Contract to which the Company or any of its Subsidiaries is a party
or by which the Company or any of its Subsidiaries is bound that
covers any Company employees. None of the employees of the
Company or any of its Subsidiaries are represented by any union
with respect to their employment by the Company or such Subsidiary,
and no labor organization or group of employees of the Company or
any of its subsidiaries has made a pending demand for recognition
or certification to the Company or any of its Subsidiaries and, to
the Knowledge of the Company, there are no representation or
certification proceedings or petitions seeking a representation
proceeding presently pending or threatened in writing to be brought
or filed with the National Labor Relations Board or any other
Governmental Entity. Since January 1, 2004, neither the
Company nor any of its Subsidiaries has experienced any material
labor disputes, union organization attempts or work stoppages,
slowdowns or lockouts due to labor disagreements.
(ii)
Except as would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse
Effect: (A) neither the Company nor any of its Subsidiaries is
delinquent in payments to any of its employees for any wages,
salaries, commissions, bonuses or other direct compensation for any
services performed for it or amounts required to be reimbursed to
such employees, (B) no employee of the Company at the officer level
or above has given written notice to the Company or any of its
Subsidiaries that any such employee intends to terminate his or her
employment with the Company or any of its Subsidiaries, (C) to the
Knowledge of the Company, no employee or former employee of the
Company or any of its Subsidiaries is in any respect in violation
of any term of any employment contract, nondisclosure agreement,
common law nondisclosure obligations, non-competition agreement, or
any restrictive covenant to a former employer relating to the right
of any such employee to be employed by the
22
-
-
Company or any of its Subsidiaries because of the
nature of the business conducted or presently proposed to be
conducted by the Company or any of its Subsidiaries or to the use
of trade secrets or proprietary information of others.
(iii)
Except as would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse
Effect, (A) each of the Company and its Subsidiaries is in
compliance with all applicable Laws and collective bargaining
agreements respecting employment and employment practices, terms
and conditions of employment, wages and hours and occupational
safety and health; and (B) each individual who renders
services to the Company or any of its Subsidiaries who is
classified by the Company or such subsidiary, as applicable, as
having the status of an independent contractor or other
non-employee status for any purpose (including for purposes of
taxation and tax reporting and under Company Benefit Plans) is
properly so characterized.
(l)
Benefit Plans .
-
-
(i)
Section 3.01( l )(i) of the Company
Disclosure Schedule contains a complete and accurate list of each
"employee benefit plan" (within the meaning of Section 3(3) of the
Employee Retirement Income Security Act of 1974, as amended ("
ERISA ") including multiemployer plans within the meaning of
Section 3(37) of ERISA), whether or not subject to ERISA and all
employment, employee loan, collective bargaining, bonus, pension,
profit sharing, deferred compensation, incentive compensation,
stock ownership, stock purchase, stock appreciation, restricted
stock, stock option, "phantom" stock, retirement, thrift savings,
stock bonus, paid time off, fringe benefit, vacation, severance,
retention, change in control, and all other employee benefit plans,
programs, policies or Contracts maintained, contributed to or
required to be maintained or contributed to by the Company or any
of its Subsidiaries or any other person or entity that, together
with the Company, is treated as a single employer under Section
414(b), (c), (m) or (o) of the Code (each, a " Commonly
Controlled Entity ") (exclusive of any such plan, program,
policy or Contract mandated by and maintained solely pursuant to
applicable Law), in each case providing benefits to any Company
Personnel (collectively, the " Company Benefit Plans
") and each Company Benefit Agreement (exclusive of local offer
letters mandated under applicable non-U.S. law that do not impose
any severance obligations other than any mandatory statutory
severance); provided , however , that (x) with
respect to Company Benefit Plans maintained solely for service
providers outside of the United States (each, a " Non-U.S.
Company Benefit Plan ), the term Company Benefit Plans for
purposes of this Agreement shall mean any material Non-U.S. Company
Benefit Plans, (y) the Company shall not be required to list
Non-U.S. Company Benefit Plans on Section 3.01( l )(i) of
the Company Disclosure Schedule as of the date of this Agreement
but shall supplement such schedule to add such plans no later than
20 days following the date hereof and (z) individual option and
restricted stock unit award agreements issued under the Company
Stock Plans need not be listed on Section 3.01( l )(i) of
the Company Disclosure Schedule. Each Company Benefit Plan
that is an "employee pension benefit plan" (as defined in Section
3(2) of ERISA) is sometimes referred to herein as a " Company
Pension Plan " and each
23
-
-
Company Benefit Plan that is an "employee welfare
benefit plan" (as defined in Section 3(1) of ERISA) is sometimes
referred to herein as a " Company Welfare Plan ."
(ii)
The Company has provided (or, in the case of
Non-U.S. Company Benefit Plans, shall provide no later than 20 days
following the date hereof) to Parent current, complete and accurate
copies of (A) each Company Benefit Plan (or, with respect to any
unwritten Company Benefit Plans, accurate descriptions thereof) and
Company Benefit Agreements, (B) for the two most recent years (1)
annual reports on Form 5500 required to be filed with the Internal
Revenue Service (the " IRS ") or any other Governmental
Entity with respect to each Company Benefit Plan (if any such
report was required) and all schedules and attachments thereto, (2)
audited financial statements and (3) actuarial valuation reports,
(C) the most recent summary plan description and any summary of
material modifications thereto for each Company Benefit Plan for
which such summary plan description is required, (D) each trust
Contract and insurance or group annuity Contract relating to any
Company Benefit Plan and (E) the most recent favorable IRS
determination letter, to the extent applicable.
(iii)
Except as would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse
Effect, (A) each Company Benefit Plan has been administered in all
respects in accordance with its terms, and the Company, its
Subsidiaries and all the Company Benefit Plans are in compliance in
all respects with the applicable provisions of ERISA, the Code and
all other applicable Laws and the terms of all collective
bargaining Contracts, and (B) all Company Pension Plans intended to
be qualified within the meaning of Section 401(a) of the Code have
received favorable determination letters from the IRS, to the
effect that such Company Pension Plans are so qualified and exempt
from Federal income Taxes under Sections 401(a) and 501(a),
respectively, of the Code, no such determination letter has been
revoked (nor, to the Knowledge of the Company, has revocation been
threatened) and no event has occurred since the date of the most
recent determination letter relating to any such Company Pension
Plan that would reasonably be expected to adversely affect the
qualification of such Company Pension Plan or increase the costs
relating thereto or require security under Section 307 of
ERISA. The Company has provided to Parent a complete and
accurate list of all amendments to any Company Pension Plan as to
which a favorable determination letter has not yet been
received.
(iv)
Neither the Company nor any Commonly Controlled
Entity has, during the six-year period ending on the date hereof,
maintained, contributed to or been required to contribute to any
Company Pension Plan that is subject to Title IV of ERISA or
Section 412 of the Code, or any "multiemployer plan" as defined in
Section 3(37) or 4001(a)(3) of ERISA. Except as would not,
individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect, (A) neither the Company nor any
Commonly Controlled Entity has any unsatisfied liability under
Title IV of ERISA, (B) to the Knowledge of the Company, no
condition exists that presents a risk to the Company or any
Commonly Controlled Entity of incurring a liability under Title IV
of ERISA, and (C) no event has occurred, and to the Knowledge
of the Company no condition exists, that would be reasonably
expected to subject the Company, any Subsidiary or
Commonly
24
-
-
Controlled Entity, to any Tax, fine, Lien,
penalty or other liability imposed by ERISA, the Code or other
applicable laws, rules and regulations.
(v)
Except as would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse
Effect, (A) none of the Company or any of its Subsidiaries has
received notice of and, to the Knowledge of the Company, there are
no Actions by any Governmental Entity with respect to, or other
claims (except claims for benefits payable in the normal operation
of the Company Benefit Plans), suits or proceedings against or
involving any Company Benefit Plan or asserting any rights or
claims to benefits under any Company Benefit Plan that are pending
or threatened that could reasonably be expected to give rise to any
material liability and (B) to the Knowledge of the Company,
there are not any facts that could give rise to
|